Magenta Medical closes $55M funding to support miniature heart pump

Miniature heart pump developer Magenta Medical announced today that it raised $55 million in a financing round led by OrbiMed.

Existing investors New Enterprise Associates, Pitango VC and ALIVE – Israel HealthTech Fund all participated, too.

Magenta said it intends to use proceeds to advance its clinical programs in the U.S. toward a first FDA approval.

The Kadima, Israel–based company develops a percutaneous left ventricular assist device (LVAD). The powerful heart pump is initially folded, inserted through the groin using a small puncture, and expanded to activate inside the left ventricle. The clinical circumstances of the patient determine how the flow of the pump adjusts. This ranges up to the entire cardiac output, allowing the heart to rest and the patient to recover.

Magenta said that, once approved, physicians can use the device to treat mechanical circulatory support (MCS) patients. This could eliminate the need to escalate therapy…

Read more
  • 0

Magenta Medical closes $55M funding to support miniature heart pump

Miniature heart pump developer Magenta Medical announced today that it raised $55 million in a financing round led by OrbiMed.

Existing investors New Enterprise Associates, Pitango VC and ALIVE – Israel HealthTech Fund all participated, too.

Magenta said it intends to use proceeds to advance its clinical programs in the U.S. toward a first FDA approval.

The Kadima, Israel–based company develops a percutaneous left ventricular assist device (LVAD). The powerful heart pump is initially folded, inserted through the groin using a small puncture, and expanded to activate inside the left ventricle. The clinical circumstances of the patient determine how the flow of the pump adjusts. This ranges up to the entire cardiac output, allowing the heart to rest and the patient to recover.

Magenta said that, once approved, physicians can use the device to treat mechanical circulatory support (MCS) patients. This could eliminate the need to escalate therapy…

Read more
  • 0